Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine
Multiple sclerosis is the predominant autoimmune disorder affecting the central nervous system in adolescents and adults. Specific treatments are categorized as disease-modifying, whereas others are symptomatic treatments to alleviate painful symptoms. Currently, no singular conventional therapy is...
Saved in:
Main Authors: | Roua A. Nouh (Author), Ahmed Kamal (Author), Oluwaseyi Oyewole (Author), Walaa A. Abbas (Author), Bishoy Abib (Author), Abdelrouf Omar (Author), Somaia T. Mansour (Author), Anwar Abdelnaser (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cannabinoids and Multiple Sclerosis: A Critical Analysis of Therapeutic Potentials and Safety Concerns
by: Roua A. Nouh, et al.
Published: (2023) -
Exploring the efficacy of cannabinoids in the management of multiple sclerosis
by: Aleksandra Rykucka, et al.
Published: (2024) -
Cannabinoids in hyperhidrosis
by: Till Kaemmerer, et al.
Published: (2023) -
The biosynthesis of the cannabinoids
by: M. Nazir Tahir, et al.
Published: (2021) -
The Antimicrobial Activity of Cannabinoids
by: John A. Karas, et al.
Published: (2020)